Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 3
2009 4
2010 3
2011 3
2012 4
2013 3
2014 4
2015 10
2016 8
2017 3
2018 5
2019 7
2020 7
2021 7
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators. Cohen EEW, et al. Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Lancet. 2019. PMID: 30509740 Clinical Trial.
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations.
Ho AL, Brana I, Haddad R, Bauman J, Bible K, Oosting S, Wong DJ, Ahn MJ, Boni V, Even C, Fayette J, Flor MJ, Harrington K, Kim SB, Licitra L, Nixon I, Saba NF, Hackenberg S, Specenier P, Worden F, Balsara B, Leoni M, Martell B, Scholz C, Gualberto A. Ho AL, et al. Among authors: specenier p. J Clin Oncol. 2021 Jun 10;39(17):1856-1864. doi: 10.1200/JCO.20.02903. Epub 2021 Mar 22. J Clin Oncol. 2021. PMID: 33750196 Free PMC article. Clinical Trial.
Nivolumab in melanoma.
Specenier P. Specenier P. Expert Rev Anticancer Ther. 2016 Dec;16(12):1247-1261. doi: 10.1080/14737140.2016.1249856. Epub 2016 Nov 7. Expert Rev Anticancer Ther. 2016. PMID: 27776441 Review.
Ipilimumab in melanoma.
Specenier P. Specenier P. Expert Rev Anticancer Ther. 2016 Aug;16(8):811-26. doi: 10.1080/14737140.2016.1211936. Epub 2016 Jul 25. Expert Rev Anticancer Ther. 2016. PMID: 27403706 Review.
Antineoplastic therapy-induced pulmonary toxicity.
Sadowska AM, Specenier P, Germonpre P, Peeters M. Sadowska AM, et al. Among authors: specenier p. Expert Rev Anticancer Ther. 2013 Aug;13(8):997-1006. doi: 10.1586/14737140.2013.817684. Expert Rev Anticancer Ther. 2013. PMID: 23984900 Review.
Ipilimumab in melanoma.
Specenier P. Specenier P. Expert Rev Anticancer Ther. 2012 Dec;12(12):1511-21. doi: 10.1586/era.12.132. Epub 2012 Nov 26. Expert Rev Anticancer Ther. 2012. PMID: 23181437
69 results